Exact Mass: 678.326

Medicagenic acid 3-O-b-D-glucuronide

C36H54O12 (678.3615)

Medicagenic acid 3-O-b-D-glucuronide is found in cereals and cereal products. Medicagenic acid 3-O-b-D-glucuronide is a constituent of the roots of Medicago sativa (alfalfa) Constituent of the roots of Medicago sativa (alfalfa). Medicagenic acid 3-O-b-D-glucuronide is found in cereals and cereal products.

1-Acetyl-3,14,20-trihydroxywitha-5,24-dienolide 3-glucoside

C36H54O12 (678.3615)

1-Acetyl-3,14,20-trihydroxywitha-5,24-dienolide 3-glucoside is found in fruits. 1-Acetyl-3,14,20-trihydroxywitha-5,24-dienolide 3-glucoside is a constituent of Physalis peruviana (Cape gooseberry).

Hv-NCC-1

C35H42N4O10 (678.2901)

So-NCC-2 is found in brassicas. So-NCC-2 is isolated from spinach. Isolated from spinach. So-NCC-2 is found in brassicas.

Galnon

C40H46N4O6 (678.3417)

PA(10:0/6 keto-PGF1alpha)

C33H59O12P (678.3744)

PA(10:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/6 keto-PGF1alpha), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(6 keto-PGF1alpha/10:0)

C33H59O12P (678.3744)

PA(6 keto-PGF1alpha/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/10:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/TXB2)

C33H59O12P (678.3744)

PA(10:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/TXB2), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(TXB2/10:0)

C33H59O12P (678.3744)

PA(TXB2/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/10:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Bryoamaride

C36H54O12 (678.3615)

Origin: Plant; SubCategory_DNP: Triterpenoids

Khekadaengoside D

C36H54O12 (678.3615)

1-(2-methylpropanoyl)-3-acetyl-11-methoxymeliacarpinin

C34H46O14 (678.2887)

Nicandrose B

C32H54O15 (678.3463)

Arvenin III

C36H54O12 (678.3615)

Hovetrichoside H

C36H54O12 (678.3615)

Toxiusol

C36H54O8S2 (678.326)

Jatamanvaltrate D

C34H46O14 (678.2887)

junceol D

C35H50O13 (678.3251)

Phrygioside B

C33H58O12S (678.3649)

S4:20(P3:18/F1:2)

C32H54O15 (678.3463)

Annotation level-3

C34H46O14

C34H46O14 (678.2887)

6-O-Acetyl-2,3,4-tri-O-(3S-methylpentanoyl)-alpha-D-glucopyranosyl-beta-D-fructofuranoside|6-O-acetyl-2,3,4-tri-O-<(S)-3-methylpentanoyl>sucrose|6-O-acetyl-2,3,4-tri-O-<3S-methylpentanoyl>-sucrose

C32H54O15 (678.3463)

24-O-(3-O-Methyl-4-O-Sulfo-beta-D-xylofuranoside)-Cholestane-3,6,8,15,24-pentol

C33H58O12S (678.3649)

19-hydroxy-3-epi-ervafolidine|19S-Hydroxy-3-epiervafoline

C40H46N4O6 (678.3417)

4-acetoxy-1beta-(2-methylbutyryloxy)-8,10-epoxyabrotanifolone

C35H50O13 (678.3251)

3beta-(O4-glucopyranosyl-O3-methyl-beta-D-xylo-2,6-dideoxy-hexopyranosyloxy)-14-hydroxy-5beta-14beta-carda-16,20(22)-dienolide|3beta-(O4-Glucopyranosyl-O3-methyl-beta-D-xylo-2,6-didesoxy-hexopyranosyloxy)-14-hydroxy-5beta-14beta-carda-16,20(22)-dienolid

C36H54O12 (678.3615)

crocetin monogentibiosyl ester

C34H46O14 (678.2887)

1alpha,6beta-diacetoxy-2alpha,9beta-dibenzoyloxy-15-isobutanoyloxy-beta-dihydroagarofuran|fokienagarofuran C

C38H46O11 (678.304)

erythroxanthin sulphate

C40H54O7S (678.359)

MS000072002

C36H54O12 (678.3615)

19R-Hydroxyervafolidine

C40H46N4O6 (678.3417)

2,3-di-O-(5-methylheptanoyl)-1,6-di-O-acetylsucrose

C32H54O15 (678.3463)

C41H38N6O4

C41H38N6O4 (678.2954)

C33H58O12S

C33H58O12S (678.3649)

3beta-(O4-beta-D-Digitoxopyranosyl-beta-D-digitoxopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolid|3beta-(O4-beta-D-digitoxopyranosyl-beta-D-digitoxopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolide

C36H54O12 (678.3615)

eremophiloside F

C36H54O12 (678.3615)

C32H54O15

C32H54O15 (678.3463)

2-O-acetyl-3-O-decanoyl-3,4-di-O-isobutyrylsucrose

C32H54O15 (678.3463)

Di-Ac-Orthenthose

C32H54O15 (678.3463)

adociasulfate 12

C36H54O8S2 (678.326)

2alpha,7alpha-diacetoxy-1alpha,11alpha-dibenzoyloxy-3alpha,8beta-dihydroxyisopimar-14-one|orthoarisin E

C38H46O11 (678.304)

3alpha,7alpha-diacetoxy-1alpha,11alpha-dibenzoyloxy-2alpha,8beta-dihydroxyisopimar-14-one|orthoarisin F

C38H46O11 (678.304)

cayaponoside B4

C36H54O12 (678.3615)

sulfangolid D ammonium salt

C36H54O10S (678.3438)

premyrsinol-3-propanoate-5-(alpha-methyl)butyrate-7,13-diacetate-17-isobutyrate

C36H54O12 (678.3615)

sucrose 2,6,3,4-tetraisovalerate

C32H54O15 (678.3463)

briaexcavatin G

C35H50O13 (678.3251)

Jatrophane 7

C34H46O14 (678.2887)

Zaragozic acid D

C34H46O14 (678.2887)

Oleaside C

C36H54O12 (678.3615)

sucrose ester MW 678

C32H54O15 (678.3463)

C36H54O12

C36H54O12 (678.3615)

(+)-miyakolide|Miyakolide

C36H54O12 (678.3615)

2,4,1-tri-O-(3-methylbutyryl)-3-O-(2-methylbutyryl)-sucrose

C32H54O15 (678.3463)

Antibiotic A 54556D

C35H46N6O8 (678.3377)

Ile Glu Arg Asp Phe

C30H46N8O10 (678.3337)

Leu Gln Tyr Lys Asn

C31H50N8O9 (678.3701)

3-(2-methylbutanoyl)-1,3,4-tri(isovaleryl)sucrose

C32H54O15 (678.3463)

C36H54O12_Estr-5-ene-3,11-dione, 17-[(1R,3E)-1,5-dihydroxy-1,5-dimethyl-2-oxo-3-hexen-1-yl]-2-(beta-D-glucopyranosyloxy)-16-hydroxy-4,4,9,14-tetramethyl-, (2beta,9beta,10alpha,16alpha,17beta)

C36H54O12 (678.3615)

C36H54O12_2,7-Octadienoic acid, 6-[[3,4-bis-O-[(2E)-6-hydroxy-2,6-dimethyl-1-oxo-2,7-octadien-1-yl]-beta-D-glucopyranosyl]oxy]-2,6-dimethyl-, (2E)

C36H54O12 (678.3615)

C32H54O15_1,3,4,6-Tetrakis-O-(3-methylbutanoyl)-beta-D-fructofuranosyl alpha-D-glucopyranoside

C32H54O15 (678.3463)

C32H54O15_1,3,6-Tris-O-(3-methylbutanoyl)-beta-D-fructofuranosyl 2-O-(3-methylbutanoyl)-alpha-D-glucopyranoside

C32H54O15 (678.3463)

C34H46O14_Propanoic acid, 2-methyl-, (2R,3R,3aS,4R,6S,7R,10E,12R,13aR)-2,3,4,6,13a-pentakis(acetyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-2,9,9,12-tetramethyl-5-methylene-8,13-dioxo-1H-cyclopentacyclododecen-7-yl ester

C34H46O14 (678.2887)

Medicagenic acid base + O-HexA

C36H54O12 (678.3615)

Annotation level-3

IERDF

C30H46N8O10 (678.3337)

LRDLY

C31H50N8O9 (678.3701)

Erythroxanthin sulfate

C40H54O7S (678.359)

1-Acetyl-3,14,20-trihydroxywitha-5,24-dienolide 3-glucoside

C36H54O12 (678.3615)

Medicagenic acid 3-O-b-D-glucuronide

C36H54O12 (678.3615)

Hv-NCC-1

C35H42N4O10 (678.2901)

6-O-succinyl methyl ester macrolactin O

C35H50O13 (678.3251)

OKODiA-PG

C32H55O13P (678.338)

2-(2-Ethoxyphenyl)-4,5-diphenylimidazole-1,2-dimer

C46H38N4O2 (678.2995)

9H-Fluoren-2-aMine, N-[1,1-biphenyl]-4-yl-9,9-diMethyl-N-[4-(9-phenyl-9H-carbazol-3-yl)phenyl]-

C51H38N2 (678.3035)

R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt

C38H51N2O7P (678.3434)

N2,N7-DIPHENYL-N2,N7-DI-M-TOLYL-9,9-SPIROBI[FLUORENE]-2,7-DIAMINE

C51H38N2 (678.3035)

TRT-CYS(TRT)-OHDEA

C45H46N2O2S (678.328)

Galnon

C40H46N4O6 (678.3417)

meso-Tetrakis(2-N-methylpyridyl)porphine

C44H38N8+4 (678.3219)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors D000890 - Anti-Infective Agents D003879 - Dermatologic Agents D004791 - Enzyme Inhibitors

Atractysucrose IIIa

C32H54O15 (678.3463)

Maropitant citrate

C38H50N2O9 (678.3516)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

[6-[4-Acetyloxy-3-hydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-di(hexanoyloxy)-2-(hydroxymethyl)oxan-3-yl] hexanoate

C32H54O15 (678.3463)

sucrose-2,3,4-tri-(3-methyl)pentanoyl-6-O-acetate

C32H54O15 (678.3463)

Sucrose-2-(2-methyl)butyryl-4-(2-methyl)butyryl-3-(4-methyl)pentanoyl-6-isobutyrate

C32H54O15 (678.3463)

PA(10:0/6 keto-PGF1alpha)

C33H59O12P (678.3744)

PA(6 keto-PGF1alpha/10:0)

C33H59O12P (678.3744)

PA(10:0/TXB2)

C33H59O12P (678.3744)

PA(TXB2/10:0)

C33H59O12P (678.3744)

4-(dimethylamino)-N-[[(3R,9R,10S)-16-[(4-fluorophenyl)sulfonylamino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C34H51FN4O7S (678.3462)

CID 73707347

C32H50N6O10 (678.3588)

(1R,2R,3aR,5R,6E,10R,11S,13R,13aS)-1,3,3a,5,8,10,11,12,13,13a-Decahydro-1,2,3a,11,13-pentaacetoxy-10-(isobutyryloxy)-2,5,8,8-tetramethyl-12-methylene-4H-cyclopentacyclododecene-4,9(2H)-dione

C34H46O14 (678.2887)

Smgdg O-22:3_2:0

C33H58O12S (678.3649)

Smgdg O-20:3_4:0

C33H58O12S (678.3649)

Smgdg O-16:3_8:0

C33H58O12S (678.3649)

Smgdg O-8:0_16:3

C33H58O12S (678.3649)

Smgdg O-18:3_6:0

C33H58O12S (678.3649)

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C32H55O13P (678.338)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C32H55O13P (678.338)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C32H55O13P (678.338)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C36H55O10P (678.3533)

SMGDG O-23:4;O

C32H54O13S (678.3285)

SMGDG O-24:3

C33H58O12S (678.3649)

SQDG 23:3;O

C32H54O13S (678.3285)

SQDG 24:2

C33H58O12S (678.3649)

DGGA 27:6;O

C36H54O12 (678.3615)

PA 20:4/13:4;O2

C36H55O10P (678.3533)

PA 20:5/13:3;O2

C36H55O10P (678.3533)

PA 33:8;O2

C36H55O10P (678.3533)

PG O-27:4;O3

C33H59O12P (678.3744)

PG P-16:0/11:3;O3

C33H59O12P (678.3744)

PG P-20:0/7:3;O3

C33H59O12P (678.3744)

PG P-20:1/7:2;O3

C33H59O12P (678.3744)

PG 14:0/13:3;O2

C33H59O12P (678.3744)

PG 14:1/12:3;O3

C32H55O13P (678.338)

PG 18:1/8:3;O3

C32H55O13P (678.338)

PG 18:2/8:2;O3

C32H55O13P (678.338)

PG 18:2/9:1;O2

C33H59O12P (678.3744)

PG 20:0/7:3;O2

C33H59O12P (678.3744)

PG 20:1/7:2;O2

C33H59O12P (678.3744)

PG 22:2/5:1;O2

C33H59O12P (678.3744)

PG 22:6/7:3;O

C35H51O11P (678.3169)

PG 27:3;O2

C33H59O12P (678.3744)

PG 29:9;O

C35H51O11P (678.3169)

LPIP 18:1

C27H52O15P2 (678.2781)

LPI 24:3

C33H59O12P (678.3744)

PI O-20:2/4:1

C33H59O12P (678.3744)

PI O-23:4;O

C32H55O13P (678.338)

PI O-24:3

C33H59O12P (678.3744)

PI P-16:0/7:3;O

C32H55O13P (678.338)

PI P-18:1/5:2;O

C32H55O13P (678.338)

PI P-20:1/4:1

C33H59O12P (678.3744)

PI P-20:1/4:1 or PI O-20:2/4:1

C33H59O12P (678.3744)

PI P-24:2

C33H59O12P (678.3744)

PI P-24:2 or PI O-24:3

C33H59O12P (678.3744)

LPI 22:5;O2

C31H51O14P (678.3016)

PI 14:1/8:3;O

C31H51O14P (678.3016)

PI 18:3/4:1;O

C31H51O14P (678.3016)

PI 22:4;O

C31H51O14P (678.3016)

ST 28:6;O8;GlcA

C34H46O14 (678.2887)

ST 29:5;O7;GlcA

C35H50O13 (678.3251)

ST 29:6;O8;Hex

C35H50O13 (678.3251)

[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-4-({[(2r)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoyl]oxy}methyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl]methyl 2-hydroxybenzoate

C34H46O14 (678.2887)

(2s,3s,3ar,4s,6r,7s,12s,13as)-2,3,4,6,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C34H46O14 (678.2887)

4-[(3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5s,6r)-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C36H54O12 (678.3615)

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-bis[(2-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}oxan-4-yl pentanoate

C32H54O15 (678.3463)

2-{[3-(acetyloxy)-6-(hydroxymethyl)-4,5-bis[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-4-hydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl decanoate

C32H54O15 (678.3463)

(2r,3r,3as,4r,6s,7s,12s,13ar)-2,3,4,6,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C34H46O14 (678.2887)

8-hydroxy-1-(hydroxymethyl)-5,6,12,12,19-pentamethyl-23-oxo-24-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-15-ene-9-carboxylic acid

C36H54O12 (678.3615)

(1s,2s,3s,4r,5s,7s,8r,9r,10s,12z,14s,17r)-2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

C35H50O13 (678.3251)

(2s,3s,4s,5s,6r)-2-{[(2r,3r,4s,5r,6r)-5-hydroxy-2-{[(2e,6e,10e)-12-hydroxy-2,6,10-trimethyldodeca-2,6,10-trien-1-yl]oxy}-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C32H54O15 (678.3463)

2-({5-hydroxy-2-[(12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol

C32H54O15 (678.3463)

9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-1-{[(2-methylpropanoyl)oxy]methyl}-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-2-yl 2-methylbutanoate

C36H54O12 (678.3615)

2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

C35H50O13 (678.3251)

(2r,3r,4r,5r,6s)-2-{[(2r,3r,4s,5r,6r)-5-hydroxy-2-{[(2e,6e,10e)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C32H54O15 (678.3463)

(3s,4s,6r,7r)-1-[(4r,5r,7e)-4-(acetyloxy)-5-methyl-8-phenyloct-7-en-1-yl]-4,7-dihydroxy-6-(octanoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C34H46O14 (678.2887)

bis((12r)-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene)

C40H42N2O8 (678.2941)

(2e,4e)-n-[(1s)-1-{[(3s,7s,13s,16s,19s)-15-hydroxy-13,16,17-trimethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]hexa-2,4-dienimidic acid

C35H46N6O8 (678.3377)

(2r,3r,3as,4r,6s,7r,12r,13ar)-2,3,4,7,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-6-yl 2-methylpropanoate

C34H46O14 (678.2887)

(1s,2s,3s,4r,7s,8z,10r,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl (2r)-2-methylbutanoate

C35H50O13 (678.3251)

methyl 2-[(13e)-1,11,16,21-tetrahydroxy-10,20,24,29-tetramethyl-5-(2-methylprop-1-en-1-yl)-9,25-dioxo-4,8,27,28-tetraoxapentacyclo[17.7.1.1³,⁷.1¹¹,¹⁵.0²¹,²⁶]nonacosan-13-ylidene]acetate

C36H54O12 (678.3615)

[6-(acetyloxy)-4a,7-dihydroxy-4-[({3-methyl-2-[(3-methylbutanoyl)oxy]butanoyl}oxy)methyl]-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl]methyl 2-hydroxybenzoate

C34H46O14 (678.2887)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4r,5r)-2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(2-methylpropanoyl)oxy]oxan-3-yl decanoate

C32H54O15 (678.3463)

2,3,4,6,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C34H46O14 (678.2887)

(2r,3as,9ar,9br,11ar)-1-(2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

(2r,3r,3as,4r,6s,7r,12r,13ar)-2,3,4,6,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C34H46O14 (678.2887)

methyl (1s,4s,5r,6s,7r,8s,10r,14r,15s,16r,18s,19r,22r,23r,25s,26s)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-25-[(2-methylpropanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C34H46O14 (678.2887)

(1r,2r,3as,3bs,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,3r,4e)-2,3,6-trihydroxy-6-methylhept-4-en-2-yl]-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

{4-[(9e,11e,13e,15e,17e)-18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethyl-2-oxocyclohex-3-en-1-yl}oxidanesulfonic acid

C40H54O7S (678.359)

4-[(3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4r,5s,6s)-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C36H54O12 (678.3615)

[(1r,2s,3e,5s,7s,8z,10r,13s)-2,5,7,9,10,13-hexakis(acetyloxy)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate

C34H46O14 (678.2887)

18-({4,5-dihydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,15-dione

C36H54O12 (678.3615)

[4-(sulfooxy)-3-({1,2,5-trimethyl-5-[2-(1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl)ethyl]-2,3,6,7,8,8a-hexahydronaphthalen-1-yl}methyl)phenyl]oxidanesulfonic acid

C36H54O8S2 (678.326)

(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-1-{[(2-methylpropanoyl)oxy]methyl}-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-2-yl (2r)-2-methylbutanoate

C36H54O12 (678.3615)

(1s,2s,3s,3as,6r,8s,12s,13r,13as)-8,13a-bis(acetyloxy)-3-(benzoyloxy)-1,12,13-trihydroxy-2,5,9,9,12-pentamethyl-1h,2h,3h,3ah,6h,7h,8h,13h-cyclopenta[12]annulen-6-yl benzoate

C38H46O11 (678.304)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r)-2,5-bis[(acetyloxy)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(5s)-5-methylheptanoyl]oxy}oxan-3-yl (5r)-5-methylheptanoate

C32H54O15 (678.3463)

(3-{[(1s,2r,5r,8as)-5-{2-[(1s,2s,4ar)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-1,2,5-trimethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(sulfooxy)phenyl)oxidanesulfonic acid

C36H54O8S2 (678.326)

(2r,3r)-3-{[(1s)-1-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-{[(2s)-1-hydroxy-5-(n-hydroxyformamido)-2-[(hydroxymethylidene)amino]pentylidene]amino}propanoic acid

C29H42N8O11 (678.2973)

[(1r,3s,3as,3bs,5s,5as,7s,9as,9br,11ar)-3,3b,7-trihydroxy-1-[(2r,5s)-5-{[(2r,3r,4r,5s)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]oxy}-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

C33H58O12S (678.3649)

(1s,4r,5r,6r,10s,12s,13s,16r,18s,21r)-18-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,15-dione

C36H54O12 (678.3615)

2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

C35H50O13 (678.3251)

1-[1-(acetyloxy)ethyl]-3,5-bis[(2-methylbutanoyl)oxy]-7-(2-methyloxiran-2-yl)-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl 4-(acetyloxy)-3-methylpent-2-enoate

C35H50O13 (678.3251)

methyl (1r,4r,5s,6r,7s,8r,10r,14r,15r,16s,18r,19s,22s,23s,25r,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-25-[(2-methylpropanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C34H46O14 (678.2887)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-6-({[(2r)-2-methylbutanoyl]oxy}methyl)oxan-4-yl pentanoate

C32H54O15 (678.3463)

(1r,2r,3bs,9br,11ar)-1-[(2r,4e)-2,3-dihydroxy-6-methoxy-6-methylhept-4-en-2-yl]-2,7-dihydroxy-3a,6,9b,11a-tetramethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one

C36H54O12 (678.3615)

(2s,3s,4r,5r)-2-{[(2r,3r,4s,5r,6r)-3-(acetyloxy)-6-(hydroxymethyl)-4,5-bis[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-4-hydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl decanoate

C32H54O15 (678.3463)

2-({5-hydroxy-2-[(12-hydroxy-2,6,10-trimethyldodeca-2,6,10-trien-1-yl)oxy]-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol

C32H54O15 (678.3463)

[(3s,4s,5s,6s)-6-{[(4r,7r)-7-[(1r,3s,3as,3bs,5s,5as,7s,9as,9br,11ar)-3,3b,5,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]octan-4-yl]oxy}-5-hydroxy-4-methoxyoxan-3-yl]oxidanesulfonic acid

C33H58O12S (678.3649)

2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-(2,3,6-trihydroxy-6-methylhept-4-en-2-yl)-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

2,3,4,7,13a-pentakis(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-1h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-6-yl 2-methylpropanoate

C34H46O14 (678.2887)

(1s,2r,5r,6s,8r,9r,14s,18r,19r,21s,24r)-8-hydroxy-1-(hydroxymethyl)-5,6,12,12,19-pentamethyl-23-oxo-24-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-15-ene-9-carboxylic acid

C36H54O12 (678.3615)

methyl 23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-25-[(2-methylpropanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C34H46O14 (678.2887)

(1r,2r,3as,3bs,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,3s,4e)-2,3,6-trihydroxy-6-methylhept-4-en-2-yl]-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

1-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H54O12 (678.3615)

(1s,2r,5r,7s,8r,9r,10r,13r,14s,15r,18s)-7-hydroxy-2,6,6,9-tetramethyl-15-(prop-1-en-2-yl)-18-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icosane-1,8-dicarboxylic acid

C36H54O12 (678.3615)

2-({2,5-bis[(acetyloxy)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-5-hydroxy-6-(hydroxymethyl)-3-[(5-methylheptanoyl)oxy]oxan-4-yl 5-methylheptanoate

C32H54O15 (678.3463)

[(1r,3as,3br,5r,5as,7r,9ar,9bs,11r,11as)-5-hydroxy-1-[(2r)-1-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-11-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid

C33H58O12S (678.3649)

4-{3a-hydroxy-7-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9a,11a-dimethyl-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

C36H54O12 (678.3615)

(1s,3ar,3br,7r,9s,9ar,9bs,11ar)-1-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-3a-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

C36H54O12 (678.3615)

(1s,3s,3as,4r,5r,6r,7s,7as)-1-[(1s)-1-(acetyloxy)ethyl]-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl (2e,4s)-4-(acetyloxy)-3-methylpent-2-enoate

C35H50O13 (678.3251)

[(3r,4r,5r,6s)-6-{[(3s,6r)-6-[(1r,3s,3as,3bs,5s,5as,7s,9as,9br,11ar)-3,3b,5,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-2-methylheptan-3-yl]oxy}-5-hydroxy-4-methoxyoxan-3-yl]oxidanesulfonic acid

C33H58O12S (678.3649)

methyl 2-[(1s,3s,5s,7s,10s,11s,13z,15r,16r,19r,20r,21r,24r,26s,29r)-1,11,16,21-tetrahydroxy-10,20,24,29-tetramethyl-5-(2-methylprop-1-en-1-yl)-9,25-dioxo-4,8,27,28-tetraoxapentacyclo[17.7.1.1³,⁷.1¹¹,¹⁵.0²¹,²⁶]nonacosan-13-ylidene]acetate

C36H54O12 (678.3615)

{4-[18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethyl-2-oxocyclohex-3-en-1-yl}oxidanesulfonic acid

C40H54O7S (678.359)

1-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-3a-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

C36H54O12 (678.3615)

(1r,2r,3r,4s,7r,8z,10s,12r,13r,14s,15r)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

C35H50O13 (678.3251)

(2s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-2,6a,6b,9,12a-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a,9-tricarboxylic acid

C36H54O12 (678.3615)

[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-4-[({3-methyl-2-[(3-methylbutanoyl)oxy]butanoyl}oxy)methyl]-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl]methyl 2-hydroxybenzoate

C34H46O14 (678.2887)